Nova Eye Medical LtdASX: EYE

AGM 2026 Chairmans Address

· Issued by Nova Eye Medical Ltd via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

The address highlights significant sales growth and improved profitability, particularly in the glaucoma market, with expectations for continued positive performance in the upcoming fiscal year. The Chairperson expresses gratitude to shareholders and stakeholders for their support as the company aims to expand its market presence and enhance shareholder value.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/agm-2026-chairmans-address

Watch Nova Eye Medical's latest callNova Eye Medical (ASX:EYE) Q4 2026 Earnings Call · Replay · Aug 3Read the transcript of Nova Eye Medical (ASX:EYE) Q4 2026 Earnings Call

Release

ASX RELEASE 29 October 2026 Chairperson’s Address to AGM 2026 Nova Eye Medical Limited (ASX: EYE) (Nova Eye Medical or the Company), is pleased to provide the Chairperson’s Address to the Annual General Meeting of Shareholders being held at 10:30am on 29th of October 2026. Fellow Shareholders,...

Nova Eye Medical Ltd on 6ix

In the deck

Earlier from Nova Eye Medical

Later from Nova Eye Medical

All Nova Eye Medical news releases